Abstract:Summary1. Three different α1‐adrenoceptor subtypes, designated α1A, α1B and α1D, have been cloned and identified pharmacologically in cardiomyocytes. In vitro studies have suggested that α1‐adrenoceptors play an important role in facilitating cardiac hypertrophy. However, it remains controversial as to which subtype of α1‐adrenoceptors is involved in this response. In the present study, we investigated the different role of each α1‐adrenoceptor subtype in mediating cardiomyocyte protein synthesis, which is a most important characteristic of cardiac hypertrophy in cultured neonatal rat cardiomyocytes.2. Cardiomyocyte hypertrophy was monitored by the following characteristic phenotypic changes: (i) an increase in protein synthesis; (ii) an increase in total protein content; and (iii) an increase in cardiomyocyte size.3. The role of each α1‐adrenoceptor subtype in mediating cardiomyocyte protein synthesis was investigated by the effect of specific α1‐adrenoceptor subtype‐selective antagonists on noradrenaline‐induced [3H]‐leucine incorporation. In addition, pKB values for α1‐adrenoceptor subtype‐selective antagonists were calculated and compared with the corresponding pKi values to further identify their effects.4. Activation of α1‐adrenoceptors by phenylephrine or noradrenaline in the presence of propranolol significantly increased [3H]‐leucine incorporation, protein content and cell size.5. Pre‐incubating cardiomyocytes with 5‐methyl‐urapidil, RS 17053 or WB 4101 significantly inhibited noradrenaline‐induced [3H]‐leucine incorporation. However, there was no effect when cardiomyocytes were pre‐incubated with BMY 7378. The correlation coefficients between pKB values for α1‐adrenoceptor subtype‐selective antagonists and pKi values obtained from cloned α1A‐, α1B‐ or α1D‐adrenoceptors were 0.92 (P < 0.01), 0.66 (P > 0.05) and 0.24 (P > 0.05), respectively.6. Our results suggest that the α1‐adrenoceptor is dominantly responsible for adrenergic hypertrophy of cultured cardiomyocytes in neonatal rats. The efficiency in mediating cardiomyocyte protein synthesis is α1A > α1B ≫ α1D.

Cross Talk Between Alpha_(1)- and Beta-Adrenoceptors

Crosstalk Between Adrenergic Receptors and Catalytic Receptors

Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart.

Subtype-specific α1- and β-adrenoceptor signaling in the heart

[Signal Transduction of Alpha 1-Adrenoceptors].

The Role of Α_1-Adrenoceptors in Different States of the Cardiac Myocyte

Gene Expression Profiles in Response to the Activation of Adrenoceptors in A7r5 Aortic Smooth Muscle Cells

Heterodimerization Of Beta(1)- And Beta(2)-Adrenergic Receptor Subtypes Optimizes Beta-Adrenergic Modulation Of Cardiac Contractility

Distinct Beta-Adrenergic Receptor Subtype Signaling in the Heart and Their Pathophysiological Relevance.

Different Roles of Α1‐adrenoceptor Subtypes in Mediating Cardiomyocyte Protein Synthesis in Neonatal Rats

Cross-talk of Opioid Peptide Receptor and Beta-Adrenergic Receptor Signalling in the Heart.

Heterodimerization of β <sub>1</sub> - and β <sub>2</sub> -Adrenergic Receptor Subtypes Optimizes β-Adrenergic Modulation of Cardiac Contractility

Alpha(1)-Adrenoceptor Subtypes Mediating Inotropic Responses in Rat Heart

Heterodimerization of β1- and β2-Adrenergic Receptor Subtypes Optimizes β-Adrenergic Modulation of Cardiac Contractility

Progress in adrenoceptor research]

Subtypes Optimizes -Adrenergic Modulation of Cardiac Contractility

[Effect of Alpha 1-Adrenoceptor Subtypes on Beta-Adrenoceptor Mediated Positive Inotropic Response in Rat Left Atria].

Beta(2)- But Not Beta(1)-Adrenoceptor Activation Modulates Intracellular Oxygen Availability

Position Paper Central α-Adrenoceptors Involved in Cardiovascular Regulation

Unraveling the crosstalk between renin‐angiotensin system receptors

β<sub>2</sub>- but not β<sub>1</sub>-adrenoceptor activation modulates intracellular oxygen availability